Other Non-Current Liabilities
Biogen Other Non-Current Liabilities increased by 5.2% to $787.10M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 4.7%, from $751.70M to $787.10M. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows a downward trend with a -10.9% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
Detailed definition
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peer comparison
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilitiesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.36B | $1.32B | $1.32B | $1.29B | $1.17B | $1.20B | $944.20M | $935.50M | $776.90M | $747.90M | $781.10M | $777.10M | $556.70M | $744.10M | $732.30M | $751.70M | $799.60M | $761.80M | $748.50M | $787.10M |
| QoQ Change | — | -2.8% | +0.2% | -2.5% | -9.3% | +2.6% | -21.2% | -0.9% | -17.0% | -3.7% | +4.4% | -0.5% | -28.4% | +33.7% | -1.6% | +2.6% | +6.4% | -4.7% | -1.7% | +5.2% |
| YoY Change | — | — | — | — | -13.9% | -9.1% | -28.5% | -27.4% | -33.5% | -37.6% | -17.3% | -16.9% | -28.3% | -0.5% | -6.2% | -3.3% | +43.6% | +2.4% | +2.2% | +4.7% |
Other Non-Current Liabilities at Other Companies
Frequently Asked Questions
- What is Biogen's other non-current liabilities?
- Biogen (BIIB) reported other non-current liabilities of $787.10M in Q1 2026.
- How has Biogen's other non-current liabilities changed year-over-year?
- Biogen's other non-current liabilities increased by 4.7% year-over-year, from $751.70M to $787.10M.
- What is the long-term trend for Biogen's other non-current liabilities?
- Over 5 years (2020 to 2025), Biogen's other non-current liabilities has grown at a -10.9% compound annual growth rate (CAGR), from $1.33B to $748.50M.
- What does other non-current liabilities mean?
- Miscellaneous long-term financial obligations not classified under standard debt or liability categories.